A seven-year Dutch study shows that a single baseline blood measurement of neurofilament light chain predicts the pace of ...
Dublin, Oct. 14, 2024 (GLOBE NEWSWIRE) -- The "Adrenoleukodystrophy - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering. This "Adrenoleukodystrophy - Pipeline ...
Adrenoleukodystrophy is a rare condition associated with abnormalities in myelin, the white matter that protects nerve fibers in the spinal cord and brain. It occurs due to a mutation on the X ...
Wilmington, Delaware, United States, Transparency Market Research Inc. , Feb. 14, 2025 (GLOBE NEWSWIRE) -- The global adrenoleukodystrophy drugs market (Markt für Medikamente gegen ...
Cerebral adrenoleukodystrophy is a severe form of X-linked adrenoleukodystrophy characterized by white-matter disease, loss of neurologic function, and early death. Elivaldogene autotemcel (eli-cel) ...
Neuraxpharm Group and Minoryx Therapeutics, today announce that the European Commission (EC) has granted marketing authorization under exceptional circumstances for NEZGLYAL® (leriglitazone), an ...
Neuraxpharm Group and Minoryx Therapeutics today announce that the European Commission (EC) has granted marketing authorisation under exceptional circumstances for NEZGLYAL ® (leriglitazone), an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results